Company Filing History:
Years Active: 2007
Title: The Innovations of William Michael Whalen
Introduction
William Michael Whalen is an accomplished inventor based in New London, CT. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as effective phosphodiesterase inhibitors. His work has implications for treating various central nervous system disorders.
Latest Patents
Whalen holds a patent for "Tetrahydroisoquinolinyl derivatives of quinazoline and isoquinoline." This invention pertains to substituted quinazoline and isoquinoline compounds that act as selective inhibitors of PDE-10. The patent also covers intermediates for the preparation of these compounds, pharmaceutical compositions that include them, and their use in treating certain CNS or other disorders. He has 1 patent to his name.
Career Highlights
Whalen is currently associated with Pfizer Corporation, a leading global pharmaceutical company. His role at Pfizer allows him to work on innovative solutions that address critical health issues. His expertise in medicinal chemistry has been instrumental in advancing the company's research initiatives.
Collaborations
Throughout his career, Whalen has collaborated with notable colleagues, including Martin Patrick Allen and Thomas Allen Chappie. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
William Michael Whalen's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his importance as an inventor. His work continues to pave the way for advancements in medical treatments.